These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5364087)

  • 21. [Oral absorption of an extract of the aorta wall interfering with experimental cholesterol atherosclerosis].
    Comi G; Viti G; Canneri E
    Boll Chim Farm; 1967 May; 106(5):309-21. PubMed ID: 5613024
    [No Abstract]   [Full Text] [Related]  

  • 22. [Arteriosclerosis--nicotinic acid therapy. 12. Some effects on experimental animals].
    Brattsand R; Lindström E
    Lakartidningen; 1971 Apr; 68(15):1776-82. PubMed ID: 4325229
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of nicotinic acid on the serum lipids of normal and of thyroidectomized dogs.
    Grande F
    Metabolism; 1966 Jul; 15(7):661-71. PubMed ID: 5918362
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
    Nordoy A; Gjone E
    Acta Med Scand; 1970 Dec; 188(6):487-90. PubMed ID: 5494813
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanism of stimulation of cholesterol absorption by 2-ethyl-n-caproic acid in vivo.
    Hyun SA; Vahouny V; Treadwell CR
    Biochim Biophys Acta; 1967 Apr; 137(2):306-14. PubMed ID: 6051564
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of the hypocholesterolemic drug, AY 9944, on the absorption of retinol in the rat.
    Alam NA; Glover J
    Int Z Vitaminforsch; 1970; 40(3):291-8. PubMed ID: 5450992
    [No Abstract]   [Full Text] [Related]  

  • 27. The hypocholesterolemic action of eritadenine in the rat.
    Takashima K; Izumi K; Iwai H; Takeyama S
    Atherosclerosis; 1973; 17(3):491-502. PubMed ID: 4736648
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of d,l-alpha-methyl-3, 5, 3, 5-tetraiodothyronine ethylester hydrochloride (CG-635) on experimental hypercholesterolemia and atherosclerosis in rabbits (author's transl)].
    Aonuma S; Koama Y; Yashiki S; Nakajin S; Chen I
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan; 51(1):56-67. PubMed ID: 1171031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of cetamiphen and nicotinic acid in the treatment of patients with coronary atherosclerosis].
    Savenkov PM
    Kardiologiia; 1967 Apr; 7(4):50-3. PubMed ID: 5598475
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of atromide on the endogenously-induced experimental hypercholesteremia and development lipoidosis of the aorta in rabbits].
    Metelitsa VI; Sverdlova PS; Aleksandrov AA; Zakharova MP; Daragan AG
    Kardiologiia; 1970 Sep; 10(9):25-9. PubMed ID: 5501510
    [No Abstract]   [Full Text] [Related]  

  • 31. The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver.
    Mishkel MA; Webb WF
    Biochem Pharmacol; 1967 May; 16(5):897-905. PubMed ID: 6036737
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.
    Miller NE; Clifton-Bligh P; Nestel PJ
    J Lab Clin Med; 1973 Dec; 82(6):876-90. PubMed ID: 4758739
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacology of probucol. I].
    Donatelli L
    Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in serum triglyceride and cholesterol levels independently of free fatty acid after lipolysis inhibitors.
    Tamási G; Borsy J; Gyenge R
    Biochem Pharmacol; 1970 May; 19(5):1826-30. PubMed ID: 5513963
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypolipemic activity of 1,2-alpha-oxido-4,6-androstadiene-3,17 dione (Compound 51).
    Linèt O
    Arzneimittelforschung; 1969 Nov; 19(11):1899-900. PubMed ID: 5395665
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of an inosite-nicotinic acid-ester on serum lipid changes in patients with vascular diseases].
    Hammerl H; Kränzl C; Pichler ; Studlar M
    Munch Med Wochenschr; 1969 Sep; 111(38):1912-6. PubMed ID: 5394857
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypocholesterolemic indole-2-carboxylic acids.
    Kariya T; Grisar JM; Wiech NL; Blohm TR
    J Med Chem; 1972 Jun; 15(6):659-62. PubMed ID: 5030934
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the antilipemic effect of nicotinic acid (NA) and 3-methylpyrazole-5-carboxylic acid (MPC) in rats.
    Tamási G; Borsy J; Patthy A
    Biochem Pharmacol; 1968 Sep; 17(9):1789-94. PubMed ID: 5688267
    [No Abstract]   [Full Text] [Related]  

  • 39. Lymphatic transport of cholesterol in normocholesterolemic rats treated with pravastatin, an inhibitor of HMG-CoA reductase.
    Sakono M; Ibi T; Nagao K; Ikeda I; Yamamoto K; Imaizumi K
    Atherosclerosis; 1996 Jul; 124(1):95-102. PubMed ID: 8800497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P; Echevaría-Vázquez D; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.